Acylamino-substituted heteroaromatic compounds and their use...

Details Acylamino-substituted heteroaromatic compounds and their use... Acylamino-substituted heteroaromatic compounds and their use...

2003-08-05

2008-03-04

Powers, Fiona T (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S338000, C514S361000, C514S367000, C546S270100, C548S125000, C548S163000

Reexamination Certificate

active

07338956

ABSTRACT:
The present invention relates to acylamino-substituted heteroaromatic compounds of formula I,wherein R1, R2, R3, R4and R5and X are as defined herein, to pharmaceutical compositions comprising such compounds, to methods for the stimulation of the expression of endothelial NO synthase, and methods of treatment comprising administering such compounds.

REFERENCES:
patent: 2399026 (1946-04-01), Henzi
patent: 4560549 (1985-12-01), Ritchey
patent: 4675331 (1987-06-01), Kume et al.
patent: 4929623 (1990-05-01), Abe et al.
patent: 6020470 (2000-02-01), Ueno et al.
patent: 6342514 (2002-01-01), Petrie et al.
patent: 6521754 (2003-02-01), Alanine et al.
patent: 6617359 (2003-09-01), Strobel et al.
patent: 6759412 (2004-07-01), Strobel
patent: 6812253 (2004-11-01), Strobelet al.
patent: 6949556 (2005-09-01), Strobel
patent: 2003/0055093 (2003-03-01), Strobel
patent: 2003/0134859 (2003-07-01), Yoshiya et al.
patent: 2004/0082628 (2004-04-01), Strobel
patent: 2004/0092513 (2004-05-01), Strobel
patent: 2004/0225013 (2004-11-01), Strobel
patent: 2005/0054729 (2005-03-01), Strobel
patent: 2005/0101599 (2005-05-01), Zeiher
patent: 1 277 729 (2003-01-01), None
patent: 2121394 (1972-08-01), None
patent: 1345552 (1974-01-01), None
patent: 1596383 (1981-08-01), None
patent: WO 98/11073 (1998-03-01), None
patent: WO 99/47153 (1999-09-01), None
patent: WO 00/03746 (2000-01-01), None
patent: WO 00/27394 (2000-05-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 01/97786 (2001-12-01), None
patent: WO 02/34711 (2002-05-01), None
patent: WO 02/064146 (2002-08-01), None
patent: WO 02/064545 (2002-08-01), None
patent: WO 02/064546 (2002-08-01), None
patent: WO 02/064565 (2002-08-01), None
Bellasio E et al., Sostanze A Potenziale Azione Cardiovascolare. 2-acilaminobenzimidazoli ad attivita ipotensiva, Farmaco, Ed. Sc., vol. 28, 2, 1978, pp. 164-182.
Bogoslowskii et al, Synthesis of some Derivatives of Aminoquinolines, Zhurnal Obshchei Khimii; vol. 14; 1944; pp. 316-318.
Buscemi et al, Heterocyclic Photorearrangements. Photochemical Behaviour of Some 3,5-Disubstituted 1,2,4-Oxadiazoles in Methanol at 254 nm., Journal of Heterocyclic Chem.; vol. 25; May-Jun. 1988; pp. 931-935.
Buscemi et al., Heterocyclic Photorearrangements. Photoinduced Rearrangements of 1,2,4-Oxadiazoles Substituted by an XYZ Side Chain Sequence, Journal of Heterocyclic Chem.; vol. 25; Sep.-Oct. 1988; pp. 1551-1553.
Elina et al, Tautomerism of 2-Acetylaminoquinoxalines and Their N-Oxides, Chem. Heterocyclic Compd.(Eng. transl.); No. 2; 1996; pp. 72-76.
Endres M et al., Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase, Proc. Natl. Aca. Sci. USA 95, 1998, vol. 95, pp. 8880-8885.
Harsanyi et al, Redox-Aromatisierung des 2-Oximino-1.2.3.4-tetrahydrochinoxalins und seiner Acylderivate, Chem. Ber.; No. 105; 1972; pp. 813-819.
Khristich et al, The Benzoylation of 2-Amino-1-Methylbenzimidazole, Chem. Heterocycl. Compd. (Eng. Transl.); No. 9; 1973; p. 1174.
Khristich, B.I., et al., Synthesis and Transformations of 2-Amino-3-Acyl-1-Methylbenzimidazolium Salts, Chemistry of Heterocyclic Compounds (Eng. Translation), No. 10, Oct. 1974, pp. 1225-1228.
Laufs Ulrich et al., Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors, Circulation 97, 1998, pp. 1129-1135.
Li Huige et al., Activation of Protein Kinase C(alpha) and/or (epsilon) Enhances Transciption of the Human Endothelial Nitric Oxide Synthase Gene, Mol. Pharmacol., 1998, vol. 53, pp. 630-637.
Moroi Masao et al., Interaction of Genetic Deficiency of Endothelial Nitric Oxide, Gender, and Pregnancy in Vascular Response to Injury in Mice, J. Clin. Invest., 1998, vol. 101, No. 6, pp. 1225-1232.
Nakayama Masafumi et al., T-786—>C Mutation in the 5′-Flanking Region of the Endothelial Ntric Oxide Synthase Gene Is Associated with Coronary Spasm, Clinical Investigation and Reports, Circulation 99, 1999, pp. 2864-2870.
Pilyugin V.S., et al., Synthesis and Biological Activity of Derivatives of 2-Aminobenzimidazole and Carboxylic Acids (Eng. translation), Bashk. Khim. Zh. 2001, Tom 8, No. 1, pp. 18-25.
Popov et al, Condensation of 2-Aminobenzimidazoles with o-Substituted Benzoyl Chlorides, Chem. Heterocyclic Comp. (Eng. Transl.); vol. 25(2); 1989; p. 229.
Rao et al, Synthesis of 2-Aryl-1H-s-Triazolo[1,5-a]Benzimidazoles, Synthetic Communications; No. 18; 1988; pp. 1995-2001.
Sessa William C et al., Chronic Exercise in Dogs Increases Coronary Vascular Nitric Oxide Production and Endothelial Cell Nitric Oxide Synthase Gene Expression, Circulation Research, 1994, vol. 74, No. 2, pp. 349-353.
Shepard et al, Carboxylic N,N-Diphenylcarbamic Anhydrides, New Acylating Agents, Journal Heterocyclic Chem.; No. 16; 1979; pp. 321-325.
Shiokawa et al, Studies on Benzimidazoles and related Compounds. IV. Reactivity of 2-Azido-1-methylbenzimidazole, Chem. Pharm. Bulletin; No. 19; 1971; pp. 401-408.
Simonov M., et al., Derivatives of 2-Amino-1-Methylbenzimidazole-5-Carboxylic Acid, Journal of General Chemistry of the USSR (Eng. translation), V32, 1962, pp. 2194-2196.
Takahashi et al, 1,3-Dipolar Cycloaddition Reaction with 1-Methylbenzimidazole 3-Oxide,Tetrahedron Letters No. 25; 1963; pp. 1687-1691.
Takahashi et al, Benzimiidazole N-Oxides. IV. 1,3-Dipolar Cycloaddition Reaction with 1-Methylbenzimidazole 3-Oxide, Chem, Pharm. Bull.; vol. 12; 1964; pp. 1290-1295.
Tamura et al, Syntheses and Properties of 3-Acylimino-1-alkylimidazolium and Benzimidazolium Betaines, Journal Heterocyclic Chem.; vol. 11; 1974; pp. 781-785.
Van Allen et al, The Reaction of Certain Heterocyclic Azides and triphenylphosphine, Journal Heterocyclic Chem; No. 5; Aug. 1968; pp. 471-476.
Varenne Olivier et al., Percutaneous Gene Thereapy Using Recombinant Adenoviruses Encoding Human Herpes Simplex Virus Thymidine Kinase, Human PAI-1, and Human NOS3 in Balloon-Injured Procine Coronary Arteries, Human Gene Thereapy,2000, vol. 11, pp. 1329-1339.
Wolf et al, Substituted Sulfaquinoxalines. Extension of the Glyoxalate Synthesis of 2-Aminoquinoxaline, J. Amer. Chem. Soc.; vol. 71; 1949; pp. 6-8.
Wolf et al, Substituted Sulfaquinoxalines. Some Derivatives and Isomers of 2-Sulfanilamidoquinoxaline, J. Amer. Chem. Soc.; vol. 70; 1948; p. 2572.
Bourdais, Jacques, 2-Mathylindole-3-carboxylic acid amide derivatives, Chemical Abstract summary CA78:136065 (1972).

Affiliated with

Also associated with

Rating

Acylamino-substituted heteroaromatic compounds and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylamino-substituted heteroaromatic compounds and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylamino-substituted heteroaromatic compounds and their use... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3962517